Literature DB >> 4850936

Cephalothin, carbenicillin, and gentamicin combination therapy for febrile patients with acute non-lymphocytic leukemia.

C D Bloomfield, B J Kennedy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4850936     DOI: 10.1002/1097-0142(197408)34:2<431::aid-cncr2820340229>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.

Authors:  J Kuhlmann; G Seidel; H Grötsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

2.  Septicemia in children with leukemia.

Authors:  Y DeClerck; D DeClerck; G E Rivard; P Benoit
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

3.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

4.  Clinical pharmacology of mezlocillin.

Authors:  B F Issell; G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

Review 5.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.

Authors:  D M Hahn; S C Schimpff; V M Young; C L Fortner; H C Standiford; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

7.  Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Authors:  J C Wade; S C Schimpff; K A Newman; C L Fortner; M R Moody; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

Review 8.  Current guidelines on the use of antibacterial drugs in patients with malignancies.

Authors:  K H Mayer; O H DeTorres
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.